Sleep Disorders Trial, Recruiting NCT05309473 Sponsor: Walter Reed Army Institute of Research (WRAIR) Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05309473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women (who are not pregnant or breastfeeding) between 18 and 39 years old
  • People who can show they understand the study by scoring at least 80% on a short multiple-choice quiz (one retest is allowed if the first attempt is unsuccessful)

Who may not be able to join:

  • People whose first language is not English
  • People with a Body Mass Index (BMI) of 30 or higher (BMI is a number calculated from height and weight)
  • People who currently have, or have a history of, sleep problems such as insomnia or sleep apnea, or symptoms that may suggest a sleep disorder
  • People who do not regularly get between 6 and 9 hours of sleep per night, or who do not follow a consistent sleep and wake schedule
  • People who regularly consume large amounts of caffeine or alcohol, or who smoke cigarettes regularly
  • People taking certain medications (assessed case by case — confirm with trial site)
  • People who test positive for illicit drugs
  • Women who are pregnant or breastfeeding
  • People who are currently taking part in another clinical trial
  • People who do not have a Social Security Number or Tax Identification Number (required for study payment purposes)
  • People with a history of heart disease, a neurological condition, a lung disease requiring an inhaler, kidney disease or abnormalities, liver disease or abnormalities, or a psychiatric condition that required hospitalisation or medication within the last two years, or for more than 6 continuous months in the past ten years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 301-319-3214

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Walter Reed Army Institute of Research (WRAIR)
Registry
ClinicalTrials.gov
Start date
14 March 2022
Est. completion
1 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measure the effects of sleep deprivation/sleep restriction on performance using the Psychomotor Vigilance Task (PVT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov